Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Ipsen

Clinical trials sponsored by Ipsen, explained in plain language.

Now part of Ipsen S.A. IPN EURONEXT PARIS

A global biopharmaceutical company focused on oncology, neuroscience, and rare diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 20 Not yet recruiting 1 Not yet finished but already full! 13 Completed 12 Terminated 1
Sort by
  • New hope for AML patients: experimental drug IPN60340 enters key trial

    Disease control Not yet recruiting

    This study tests whether adding the experimental drug IPN60340 to standard medicines (azacitidine and venetoclax) helps more people with newly diagnosed acute myeloid leukemia (AML) achieve complete remission. About 450 adults who cannot have intensive chemotherapy will take part…

    Phase: PHASE2, PHASE3 • Sponsor: Ipsen • Aim: Disease control

    Last updated Jun 27, 2026 13:01 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space